Olaparib After Response to Trabectedin-pegylated Liposomal Doxorubicin in Recurrent Ovarian Carcinoma
Clinical trial NCT03470805 · COMPLETED
Trial details
- NCT number
- NCT03470805
- Sponsor
- Grupo Español de Investigación en Cáncer de Ovario
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-21
- Primary completion
- 2022-07-27
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.